Cardioprotective Effects of Phlorizin on Hyperlipidemia-induced Myocardial Injury: Involvement of Suppression in Pyroptosis Via Regulating HK1/NLRP3/Caspase-1 Signaling Pathway

Overview

Journal Appl Biochem Biotechnol

Specialties Biochemistry
Biotechnology

Date 2024 Sep 2

PMID 39223343

Authors

Yuling Zhang

Yanan Wang

Xizhen Cheng

Haochuan Guo

Donglai Ma

Yongxing Song

Yajing Zhang

Hongfang Wang

Huiru Du

Affiliations

Soon will be listed here.

Abstract

Hyperlipidemia (HLP) is a prevalent and intricate condition that plays a pivotal role in impairing heart function. The primary objective of this study was to assess the lipid-lowering and cardioprotective properties of phlorizin (PHZ) and to investigate its potential molecular mechanisms in rats. In this investigation, Sprague-Dawley rats were subjected to a high-fat diet for a period of 28 days to induce an HLP model. Subsequently, the rats received oral doses of PHZ or metformin from day 14 to day 28. We assessed various parameters using commercially available kits, including serum lipid deposition, myocardial injury biomarkers, oxidative stress markers, and inflammatory cytokine levels. We also employed electron microscopy to examine myocardial ultrastructural changes and conducted Western blot analyses to assess apoptosis factors and pyroptosis markers. Comparing the PHZ group with the model group, we observed significant improvements in blood lipid deposition and heart injury biomarkers. Furthermore, PHZ demonstrated a clear reduction in myocardial tissue oxidative stress and inflammatory factors, as well as a suppression of cell apoptosis. Subsequent investigations indicated that PHZ treatment led to a decreased inflammatory response and lowered levels of hexokinase 1 (HK1), NOD-like receptor thermal protein domain associated protein 3 (NLRP3), apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), and Caspase-1. In summary, PHZ proved to be an effective remedy for alleviating HLP-induced cardiac damage by reducing blood lipid levels, mitigating oxidative stress, curbing inflammation, and suppressing pyroptosis. The inhibition of pyroptosis by PHZ appears to be linked to the regulation of the HK1/NLRP3/Caspase-1 signaling pathway.

References

Yu Y, Pan Y, Fan Z, Xu S, Gao Z, Ren Z . LuHui Derivative, A Novel Compound That Inhibits the Fat Mass and Obesity-Associated (FTO), Alleviates the Inflammatory Response and Injury in Hyperlipidemia-Induced Cardiomyopathy. Front Cell Dev Biol. 2021; 9:731365. PMC: 8647038. DOI: 10.3389/fcell.2021.731365. View

Wu W, Bao W, Chen X, Lu Y, Fang J, Liu J . Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways. Redox Biol. 2023; 64:102775. PMC: 10363430. DOI: 10.1016/j.redox.2023.102775. View

Meng M, Jia R, Wei M, Meng X, Zhang X, Du R . Oxidative stress activates Ryr2-Ca and apoptosis to promote PM-induced heart injury of hyperlipidemia mice. Ecotoxicol Environ Saf. 2022; 232:113228. DOI: 10.1016/j.ecoenv.2022.113228. View

Chen X, Yu W, Li W, Zhang H, Huang W, Wang J . An anti-inflammatory chalcone derivative prevents heart and kidney from hyperlipidemia-induced injuries by attenuating inflammation. Toxicol Appl Pharmacol. 2017; 338:43-53. DOI: 10.1016/j.taap.2017.11.003. View

Zhang L, Liu X, Huang M, Wang R, Zhu W, Li Y . Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation. Clin Cosmet Investig Dermatol. 2022; 15:1403-1413. PMC: 9326038. DOI: 10.2147/CCID.S368845. View

Pei Z, Guo Y, Zhu H, Dong M, Zhang Q, Wang F . Thymoquinone Protects against Hyperlipidemia-Induced Cardiac Damage in Low-Density Lipoprotein Receptor-Deficient (LDL-R) Mice via Its Anti-inflammatory and Antipyroptotic Effects. Biomed Res Int. 2020; 2020:4878704. PMC: 7644313. DOI: 10.1155/2020/4878704. View

Hyde M, Bagley J, Hinds P, Tsichlis P, Iacomini J . Hyperlipidemia-induced metabolic changes in regulatory T cells result in altered function. Eur J Immunol. 2021; 51(11):2576-2589. DOI: 10.1002/eji.202049149. View

Wang Y, Jin W, Wang J . Tanshinone IIA regulates microRNA‑125b/foxp3/caspase‑1 signaling and inhibits cell viability of nasopharyngeal carcinoma. Mol Med Rep. 2021; 23(5). PMC: 7985994. DOI: 10.3892/mmr.2021.12010. View

Chen J, Pan M, Wang J, Zhang M, Feng M, Chai X . Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota. Toxicol Appl Pharmacol. 2023; 467:116494. DOI: 10.1016/j.taap.2023.116494. View

10.

Peukert K, Steinhagen F, Fox M, Feuerborn C, Schulz S, Seeliger B . Tetracycline ameliorates silica-induced pulmonary inflammation and fibrosis via inhibition of caspase-1. Respir Res. 2022; 23(1):21. PMC: 8822850. DOI: 10.1186/s12931-022-01937-7. View

11.

Chen H, Dong L, Chen X, Ding C, Hao M, Peng X . Anti-aging effect of phlorizin on D-galactose-induced aging in mice through antioxidant and anti-inflammatory activity, prevention of apoptosis, and regulation of the gut microbiota. Exp Gerontol. 2022; 163:111769. DOI: 10.1016/j.exger.2022.111769. View

12.

Katsuda Y, Sasase T, Tadaki H, Mera Y, Motohashi Y, Kemmochi Y . Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin. Exp Anim. 2015; 64(2):161-9. PMC: 4427731. DOI: 10.1538/expanim.14-0084. View

13.

Menezes da Costa R, Fais R, Dechandt C, Louzada-Junior P, Alberici L, Lobato N . Increased mitochondrial ROS generation mediates the loss of the anti-contractile effects of perivascular adipose tissue in high-fat diet obese mice. Br J Pharmacol. 2016; 174(20):3527-3541. PMC: 5610168. DOI: 10.1111/bph.13687. View

14.

Gomaa A, Farghaly H, Ahmed A, Hemida F . Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats. Int Immunopharmacol. 2023; 117:109927. DOI: 10.1016/j.intimp.2023.109927. View

15.

Aslam N, Faisal M, Khan J, Majeed W . (L.) fruit extract alleviates oxidative stress through activation of dual oxidases and Keap1/Nrf2 signaling cascades in high-fat-diet associated atherosclerosis rats. Toxicol Res (Camb). 2022; 11(6):920-930. PMC: 9773065. DOI: 10.1093/toxres/tfac070. View

16.

Zhao L, Qiu X, Wang R, Wang D . H NMR-based metabolomics study of the dynamic effect of Xue-Fu-Zhu-Yu capsules on coronary heart disease rats induced by high-fat diet, coronary artery ligation. J Pharm Biomed Anal. 2021; 195:113869. DOI: 10.1016/j.jpba.2020.113869. View

17.

Maliver P, Festag M, Bennecke M, Christen F, Banfai B, Lenz B . Assessment of Preclinical Liver and Skeletal Muscle Biomarkers Following Clofibrate Administration in Wistar Rats. Toxicol Pathol. 2017; 45(4):506-525. DOI: 10.1177/0192623317707271. View

18.

Tuerdi N, Anwaier G, Zhang X, Liu S, Shen W, Liu W . Simvastatin nanoliposome induces myocardial and hepatic toxicities due to its absorption enhancement in mice. Asian J Pharm Sci. 2020; 15(1):112-120. PMC: 7066038. DOI: 10.1016/j.ajps.2019.02.002. View

19.

Sung S, Al-Karaghouli M, Kalainy S, Cabrera Garcia L, Abraldes J . A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis. BMC Gastroenterol. 2021; 21(1):120. PMC: 7967963. DOI: 10.1186/s12876-021-01704-w. View

20.

Ko M, Jo A, Kim Y, Kang S, Cho S, Jo S . Time- and Dose-Dependent Association of Statin Use With Risk of Clinically Relevant New-Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study. J Am Heart Assoc. 2019; 8(8):e011320. PMC: 6507181. DOI: 10.1161/JAHA.118.011320. View